Corteva, Inc.

Corteva, Inc. is a global pure-play agricultural sciences company that develops and supplies seeds, crop protection products, and digital tools to farmers in approximately 110 countries, generating $17.4 billion in net sales in fiscal 2025. The company operates through two segments — Seed (brands including Pioneer, Brevant, and PhytoGen) and Crop Protection (herbicides, insecticides, fungicides, and biologicals) — and was formed in June 2019 through the spin-off of DowDuPont's agriculture division.

This is a company at a genuine fork in the road. On October 1, 2025, management announced its intent to separate Seed and Crop Protection into two standalone publicly traded companies via a tax-free spin-off — a transaction now targeted to complete on October 1, 2026, precisely one year after announcement. The separation is the most consequential corporate action in Corteva's short independent history and the question the file turns on: does breaking apart a business that has already delivered $1.7 billion of Operating EBITDA improvement and 750 basis points of margin expansion since 2019 create incremental value, or does it sacrifice the portfolio logic that has supported those gains?

Other questions matter — whether Crop Protection can sustain margins as legacy molecules face generic pressure, how durable Seed's licensing income trajectory really is, whether the litigation overhang is manageable — but they are best understood through the lens of the separation. Each business faces different competitive dynamics, different capital requirements, and would likely command different valuation multiples as a standalone entity. The analysis that follows is built around understanding those differences and what they imply for the value of the combined entity today.